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Abstract 
 
Background:  Previous  methods  of  empirical  mapping  involve  using  regressions  on 
patient or general population self-report data from datasets involving 2 or more 
instruments. This approach relies on overlap in the descriptive systems of the measures, 
but key dimensions may not be present in both measures. Furthermore this assumes it is 
appropriate to use different instruments on the same population, which may not be the 
case for all patient groups. The aim of the study described here is to develop a new 
method of mapping using general population preferences for hypothetical health states 
defined  by  the  descriptive  systems  of  different  measures.  This  paper  presents  a 
description of the methods used in the study and reports on the results of the valuation 
study including details about the respondents, feasibility and quality (e.g. response rate, 
completion and consistency) and descriptive results on VAS and ranking data. The use 
these results to estimate mapping functions between instruments will be presented in a 
companion paper (Rowen et al, 2009). 
 
Methods: The study used interviewer administered versions of ranking and VAS 
techniques to value 13 health states defined by each of 6 instruments: EQ-5D (generic), 
SF-6D (generic), HUI2 (generic for children), AQL-5D (asthma specific), OPUS (social 
care specific), ICECAP (capabilities). Each interview involved 3 ranking and visual 
analogue scale (VAS) tasks with states from 3 different instruments where each task 
involves the simultaneous valuation of multiple instruments. The study includes 13 health 
and well-being states for each instrument (16 for EQ-5D) that reflect a range of health 
state values according to the published health state values for each instrument and each 
health state is valued approximately 75-100 times. 
 
Results: The sample consists of 499 members of the UK general population with a 
reasonable spread of background characteristics (response rate=55%). The study achieved 
a completion rate of 99% for all states included in the rank and rating tasks and 94.8% of 
respondents have complete VAS responses and 97.2% have complete rank responses. 
Interviewers reported that it is doubtful for 4.1% of respondents that they understood the 
tasks, and 29.3% of respondents stated that they found the tasks difficult. The results 
suggest important differences in the range of mean VAS and mean rank values per state 
across instruments, for example mean VAS values for the worst state vary across 
instruments from 0.075 to 0.324. Respondents are able to change the ordering of states 
between the rank and VAS tasks and 12.0% of respondents have one or more differences 
in their rank and VAS orderings for every task. 
 
Conclusions:  This  study  has  demonstrated  the  feasibility  of  simultaneously  valuing 
health states from different preference-based instruments.  The preliminary analyse of the 
results presented here provides the basis for a new method of mapping between measures 
based on general population preferences. 
 
Key  words:  Preference-based  measures  of  health;  quality  of  life;  mapping;  Visual 
Analogue Scale: ranking 
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1. Introduction 
Economic evaluation using preference-based measures of health to generate Quality 
Adjusted Life Years (QALYs) is being increasingly used to inform health policy. The 
QALY measure combines both quantity and quality of life into a single measure and 
quality of life is measured using a preference-based measure of health. Recent years 
has seen the increasing proliferation of preference-based measures of health. These 
fall into three categories: 
1)  Generic measures for adults such as the EQ-5D (Brooks, 1996), the HUI3 
(Feeny et al, 2002), the QWB scale (Kaplan and Anderson, 1988) and the SF- 
6D (Brazier et al, 2002) 
2)  Measures designed for specific groups, such as those for older people (Grewal 
et al, 2006), children (Torrance et al, 1996; Stevens, 2009) and social care 
(Ryan et al, 2006). 
3)  Condition-specific measures designed for specific medical conditions, such as 
those  for  asthma  (Revicki  et  al,  1998;  Young  et  al,  2007)  and  urinary 
incontinence (Yang et al, 2008). 
 
If all of these measures are preference-based, measured on an interval scale, with the 
upper anchor at full health (=1) and the lower anchor at 0 (assuming it is equivalent to 
dead) then theoretically all instruments should be comparable to each other, where the 
value of a health state for a patient is identical regardless of the instrument used. 
However this is not true in practice. The increasing number of generic and condition 
specific preference-based measures of health have been shown to generate different 
scores in the same population (Brazier et al, 2004; Longworth and Bryan, 2003; 
O’Brien et al, 2003). This can be attributed to differences in their descriptive systems 
and valuation methods (Brazier et al, 2004; Tsuchiya et al, 2006). This creates a major 
problem for researchers and policy makers undertaking evidence synthesis and cross 
programme comparisons across studies using different instruments. 
 
One solution to cross programme comparison is to use one generic preference-based 
measure in all economic evaluation (Dowie, 2002). However, this is not possible for 
all groups of patients, for example children require special consideration regarding 
language comprehension and development (Stevens, 2009), and there may be special 
considerations for very elderly people (Coast et al, 2008) and those needing social 
care (Ryan et al, 2006). Furthermore generic measures of health are inappropriate or 
insensitive for many medical conditions (for example Barton et al, 2004; Espallargues 
et al, 2005; Harper et al, 1997; Kobelt et al, 1999). Even if these arguments are not 
accepted, the fact remains that different measures are used across studies within and 
between conditions and this will continue as long as there is no common agreement 
internationally on which measure to use. 
 
Previous attempts at mapping between instruments have used existing datasets that 
have two or more measures used alongside each other, and regression analysis is 
applied to estimate a statistical relationship between the indices generated by the 
measures or their descriptive systems (for example, Franks et al, 2004; Gray et al, 
2006; Nichol et al, 2001; Tsuchiya et al, 2002). This type of mapping is commonly 
used to estimate a mapping function that will allow the estimation of a utility score 
when  no  preference-based  measure  has  been  included  in  the  trial.  This  method 
assumes it is appropriate to use different instruments on the same population, which 
as described above may not be the case for all patient groups and all conditions. This 
approach also relies on a degree of overlap in the descriptive systems of the measures, 
but key dimensions may not be present in both measures. This approach also relies on 
a distribution of patients across the states, to avoid extrapolation when the mapping 
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function is applied to the trial dataset. Instead what is needed is a means of relating 
the responses on one measure to another using a common metric and preserving the 
advantages that the descriptive system may bring. This study is testing a new method 
for mapping between preference-based measures that could be used for evidence 
synthesis and cross programme comparisons in studies using different preference- 
based measures. 
 
One possibility would be to use time trade-off (TTO) or standard gamble (SG) 
preference elicitation techniques on multiple instruments in one sitting, for example 
see Tsuchiya et al. (2006). However, given limited resources and increasing interest in 
using ordinal methods a ranking task was used alongside a visual analogue scale 
(VAS) in our current study. In addition, strictly speaking, TTO and SG are valuation 
methods where respondents deal with one state at a time, and therefore there is no 
direct  head-to-head comparison of states from different  instruments. Ranking and 
VAS offer alternative techniques that allow for the simultaneous valuation of states. 
In this paper we present the study design of this new approach to mapping. The paper 
presents a brief description of the instruments involved in this study, the methodology 
of the valuation study and the results of the valuation survey in terms of the 
background of the respondents, response rates, completion rates, consistency of 
responses and descriptive statistics on the rank and VAS data by states defined by the 
instruments.   The main aim of this paper is to demonstrate the feasibility of 
simultaneously valuing multiple instruments and to provide the basis for the 
companion paper (Rowen et al, 2009) that uses these results to map between 
instruments. 
 
1.1 Measures of health and quality of life 
The study involves 6 preference-based measures of health and quality of life: EQ-5D 
(generic), SF-6D (generic), HUI2 (generic for children), AQL-5D (asthma specific), 
OPUS (social care specific), ICECAP (capabilities). The choice of measures reflects a 
range of different types of measures that are currently in use or nearing use in the UK. 
These are summarised in table 1. 
 
The EQ-5D is the most widely used generic preference-based measure of health- 
related quality of life which produces utility scores anchored at 0 for dead and 1 for 
perfect health (Dolan, 1997). The SF-6D is a generic preference-based single index 
measure for health that can be estimated using SF-36 and SF-12 data (Brazier and 
Roberts, 2004). The SF-6D is derived from a selection of SF-36 items (Ware et al, 
1993) and produces utility scores anchored at 0 for dead and 1 for perfect health. The 
HUI2 is a generic preference-based measure of health for children (Torrance et al, 
1996) and produces utility scores anchored at 0 for dead and 1 for perfect health. The 
AQL-5D (Young et al, 2007) is a condition-specific preference-based measure of 
health for asthma derived from the Asthma Quality of Life Questionnaire (AQLQ) 
(Juniper, 1993) and produces utility scores anchored at 0 for dead and 1 for perfect 
health (Yang et al, 2007). 
 
ICECAP is a preference-based measure of capability for older people in the UK 
(Grewal et al, 2006). Utility scores are anchored at 0 for zero capabilities and 1 for 
perfect health. OPUS (older persons’ utility scale) is a preference-based social care 
outcome measure for older people (Ryan et al, 2006). We use the utility index 
excluding the safety dimension. Utility scores are anchored at 0 for the worst outcome 
(high unmet needs on all dimensions) and 1 for the best outcome (no unmet needs on 
all  dimensions).  The  choice  of  measures  reflects  a  range  of  different  types  of 
measures that are currently in use or nearing use in the UK. 
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2. Methods 
The aim of the study is to develop a preference-based method of mapping between 
preference-based instruments. Respondents’ preferences are elicited for hypothetical 
health and well-being states defined by different descriptive systems. This means that 
the  relationship  between  different  instruments  is  determined  directly  by  people’s 
preferences for different states and not by associations in self-reported values. Unlike 
mapping by statistical association this approach does not rely on conceptual overlap 
of instruments and does not rely on the distribution of patients self-reported scores to 
estimate a mapping function suitable for the full value set range. In the valuation 
study a sample of health states defined by each of 6 instruments presented above (EQ- 
5D, SF-6D, HUI2, AQL-5D, OPUS and ICECAP) are valued by a representative 
sample of the general population. 
 
2.1 Study design 
The overall aim of the study is to be able to map between instruments via a common 
yardstick. It has two stages.  The first stage is a valuation study to determine people’s 
preferences for health and well-being states described by the descriptive systems of 
different  instruments  using  VAS  and  ranking.  The  second  stage  is  to  estimate 
mapping functions between the preference-based instruments via the common 
yardstick of VAS and rank values and the published value sets of the instruments and 
to use these to map between instruments. The second part of this study is presented in 
a companion paper (Rowen et al, 2009). 
 
2.2 Valuation task 
For use in economic evaluation the health state valuation technique should be choice 
based (Drummond et al, 2005). Conventionally this has included cardinal methods 
such as standard gamble (SG) and time-trade off (TTO), yet over recent years there 
has been an increasing interest in using ordinal methods, such as ranking or pair wise 
comparisons (Salomon, 2003, 2007; McCabe et al, 2006). In a conventional ranking 
task respondents are asked to order a set of states from best to worst. 
 
An  advantage  of using  ranking  is  it  is  arguably  cognitively  less  complex  when 
eliciting preferences over health states from different instruments than TTO or SG. 
More importantly, it provides a direct means of comparing health states from different 
instruments and enables preference elicitation for a greater number of health states per 
respondent than SG or TTO.  This use of ranking to value health states is quite new, 
so we decided to also use VAS to provide another means of simultaneously valuing 
states from different instruments and another common yardstick for testing this new 
method of mapping. 
 
A conventional VAS task was used where respondents are asked to rate health states 
on a scale from 0 to 100 using a vertical line on a page, where 0 is the ‘worst 
imaginable state’ and 100 is the ‘best imaginable state’. The main difference with 
previous applications of VAS is that the end points do not specify health because 
some of the instruments do not limit themselves to health (e.g. ICECAP). There are 
concerns with the use of VAS including end point bias (Torrance et al, 2001) and that 
it does not generate ‘preferences’ (Brazier et al, 2003). However these problems are 
less relevant for this study since the aim is not to produce a new a value set per se, but 
to allow the conversion of scores from one instrument into those of another. VAS and 
ranking provide cardinal scales to value sets of states and these ‘common yardsticks’ 
can be used as a means to relate utility scores generated using the value set for one 
instrument to utility scores generated using the value set for another instrument. 
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2.3 Valuation study design 
In order to determine the relationship between instruments and to estimate this 
relationship each respondent values health states from multiple descriptive systems 
alongside each other. A respondent may value, for example, EQ-5D and SF-6D states 
during  the  same  valuation  task.    This  may  make the respondent  more aware of 
different dimensions or ways of expressing health when seeing health states from two 
descriptive systems rather than one. This may alter the way they value an instrument 
when individuals realise that some dimensions of health are explicit in one descriptive 
system but not the other. One aim of the study design was to reduce any systematic 
bias brought about through the combination of instruments and states that were valued 
by each individual both within a valuation task and across all valuation tasks for that 
individual. The study was designed so that each instrument appeared with each other 
instrument an equal number of times. 
 
Each interview involves 3 rank tasks and 3 VAS tasks. Respondents are asked to rank 
a set of 8 cards; 3 states from one instrument (mild, moderate, worst state), 3 states 
from another instrument (mild, moderate, worst state), plus ‘best state’ and ‘dead’. 
Respondents are then asked to rate these cards using VAS and are able to change the 
ordering from the previous ranking. Each interview involves 15 states in total, 5 states 
each (2 mild states, 2 moderate states, worst state) from 3 different instruments. Each 
time an instrument is included in a valuation task the worst state defined by that 
instrument is valued. 
 
There are 20 variations of the interview as there are 20 different combinations of r=3 
instruments  from  the  available  n=6  instruments  using  the  binomial  coefficient 
equation n!/(r!(n-r)!). Each variation of the interview is different and has a different 
‘card bloc’, making 20 card blocs in total. Each instrument appears in 10 out of the 20 
card blocs and hence 10 variations of the interview. The interviews are designed so 
that each health state is valued approximately 75-100 times (with the exception of 50 
times for 4 EQ-5D states) and 500 times for each worst state (since they appear in 
different combinations). 
 
Each card bloc involves 3 instruments with one ‘card set’ for each instrument, and 
each card set consists of 4 unique states of various severity plus the worst state as the 
fifth state. Each card set is used in 3 or 4 blocs
1 
and across all blocs any given card set 
appears at least once in the first ranking task, at least once in the second ranking task 
and at least once in the third ranking task. This is to minimise any data variation due 
to respondents changing their understanding, consideration and concentration across 
the duration of the interview. 
 
Figure 1 shows the task design for 6 out of the 20 card blocs. Instruments are labelled 
A, B, C, D, E and F and health states for each instrument are numbered 1 to 13, where 
1 represents the worst state of each instrument. 
 
2.4 Selection of health states 
Sixteen states were selected for the EQ-5D using an orthogonal design in SPSS to 
generate an orthogonal array of states that enable the estimation of an additive 
function to value all states. Selection of states using an orthogonal design was not 
possible for every instrument since the orthogonal array was too large, for example 49 
 
 
1 
With the exception of EQ-5D where each card set is used in 2 or 3 card blocs due to the larger 
number of states and hence card sets. 
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states for the SF-6D alone. For all other instruments twelve health and well-being 
states were selected plus the worst state. States were selected to reflect a range of 
health state values according to the published value set (or most recent version for 
AQL-5D and ICECAP) for each instrument, whilst guaranteeing that a variety of 
levels for each dimension are included in the chosen states. All health and well-being 
states were checked to guarantee that the combination of levels and dimensions were 
feasible and realistic and hence appropriate for use in ranking and VAS tasks 
undertaken by members of the general population. 
 
Instrument specific full health was not used for all instruments as instead the generic 
state ‘best state’ was used. This approach was chosen as the aim is not to focus upon 
differences or deficiencies in descriptive systems per se but to focus upon differences 
in values given to health states with different health problems. The instrument specific 
best state was only included for two instruments: EQ-5D since it is specified by 
orthogonal array, and OPUS, since it has the smallest descriptive system of all 
instruments included. 
 
2.5 The interviews 
All interviews were conducted by trained and experienced interviewers in the 
respondent’s own home. The interviews were undertaken by the Centre for Research 
and Evaluation (CRE) at Sheffield Hallam University who have done numerous 
valuation surveys including the UK valuation of HUI2 (McCabe et al, 2005), AQL- 
5D (Yang et al, 2007), OAB-5D (Yang et al, 2008), King’s Health Questionnaire 
(Brazier et al, 2008) and TTO and SG valuation of EQ-5D alongside SF-6D (Tsuchiya 
et al, 2006). Respondents were not offered any financial reward for their participation. 
 
The interview began with the respondent being asked to report their own health using 
the descriptive system for the EQ-5D and subsequently all instruments that the 
individual would value during the interview. This familiarised the respondent with the 
idea of describing states and the items and levels in the descriptive system for each of 
the instruments involved in their interview. 
 
In the next stage of the interview the respondent was asked to rank a shuffled set of 8 
cards (task 1) as described above. The respondent was asked to place the cards in 
order of how good or bad they think they are. Respondents were asked to imagine that 
they themselves were actually in each state and that it is going to last for the rest of 
their life without changing. The respondent was then asked to rate these same states 
(without reshuffling the cards) using the VAS, allowing respondents to change the 
ordering from the previous ranking. The respondent was then asked to repeat the 
ranking and VAS tasks twice with different sets of cards (tasks 2 and 3). 
 
The final stage of the interview involved self-completion questions on background 
characteristics and how difficult the respondent found the interview and interviewer 
feedback on whether the respondent understood the tasks. 
 
2.6 Selection of respondents 
Respondents were from the geographical areas in the North of England including 
urban and rural areas with a mix of socio-economic characteristics. Streets were 
sampled from the selected areas and all willing participants within quota were 
interviewed. Letters were sent to households informing them the interviewers will be 
in their area. Interviewers then visited houses and interviewed all people who were 
willing to participate and within quota from those addresses. 
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2.7 Analysis 
Raw VAS ratings measured on the 0 to 100 scale are rescaled using the following 
equation (MVH, 1994): 
 
A 
Rijk R dead ik 
ijk 
R best ik R dead ik 
 
(1) 
 
where  Aijk   represents  the  adjusted  VAS  rating  for  each  health  state  j  for  each 
individual i for each task k, R(dead)ik  represents the raw rating given to ‘dead’, Rijk 
represents the raw rating given to health state j and R(best)ik represents the raw rating 
given to the best health state. This rescales the values per task per individual such that 
the highest valued state (including the generic ‘best state’) equals 1 and dead equals 0, 
hence states can have a value worse than dead. 
 
Rank responses are scored according to their rank from 1 to 8 where 1 is the most 
preferred state and 8 is the least preferred state. Ties in rank data are scored at the 
highest rank. For example, the data is coded 1,1,1,4,5,6,7,8 for a respondent who ties 
3 states as the most preferred state. 
 
Duration, completion, difficulty self-reported by respondent, understanding and 
concentration reported by interview are reported for the easiest and most difficult card 
blocs to demonstrate the range across all card blocs. Mean and standard deviation 
(SD) of adjusted VAS score and rank score for highest and worst states by instrument 
are presented. Mean, SD, median and interquartile range (IQR) are reported for raw 
and adjusted VAS data for all states, and adjusted VAS values and rank scores are 
compared to published value sets and logical consistency is reported. For the EQ-5D, 
the predicted adjusted VAS score is compared to the published VAS value set. 
 
3. The data 
There were 502 successfully conducted interviews, a response rate of 55% for suitable 
respondents answering their door at time of interview. Amongst responders, the study 
achieved a completion rate of 99% for all states included in the rank and rating tasks 
(140 rank values and 178 VAS values missing out of 12,048 values) and 94.8% 
(476/502) of respondents had complete VAS responses and 97.2% (488/502) of 
respondents had complete rank responses. Higher response rates for ranking over 
VAS were also achieved in the MVH EQ-5D valuation survey (Gudex, 1997). Two 
respondents (0.4%) have no rank or rating responses, one respondent and one further 
task for one respondent are excluded for unusable responses (‘dead’ is valued higher 
than all states other than ‘best state’). All other responses are used in the analysis 
reported here. 
 
Characteristics of all respondents with usable rank or rating responses are presented in 
table 2 and compared to the general population in South Yorkshire and England. The 
sample population sample is broadly comparable to the regional and national 
populations, but it has a higher proportion of retired persons and home owners and 
fewer employed persons.   This is not a problem for this study since it is mainly 
concerned with the feasibility of this approach rather than generating a definitive set 
of values. 
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4. Results 
4.1 Feasibility 
Table 3 presents duration of interview, self-reported difficulty of questions and 
understanding, and effort and concentration as reported by the interviewer for a 
selection of card blocs. These card blocs were selected as they were reported as being 
the easiest and most difficult card blocs using the self-report data from respondents. 
Yet responses for difficulty, understanding and effort and concentration are similar for 
all card blocs, suggesting little variation in feasibility across blocs. Mean duration 
varies from 32 to 41 minutes across all blocs, missing VAS responses range from 0% 
(0 out of 576) to 5.1% (33 out of 648) and missing rank responses range from 0% (0 
out of 600) to 4.9% (32 out of 648) for each card bloc, with missing values seeming 
unrelated to difficulty. There is no clear pattern of difficult combinations of 
instruments, as one of the easiest and both of the most difficult blocs contain AQL-5D 
and ICECAP. 
 
4.2 Results 
Table 4 shows the highest and worst states by instrument.  The mean adjusted VAS 
value for the best states for those instruments where their  best state was valued, 
namely EQ-5D (state 11111) and OPUS (state 1111), are lower than one (i.e. 0.909 
and 0.899 respectively), indicating that these instrument specific best states are 
regarded as worse than the generic best state. The worst state is valued for all 
instruments and the VAS values range between 0.075-0.324 and rank score range 
from 5.39-6.87. This range reflects the different ‘floors’ of the instruments, with 
generic EQ-5D having the lowest floor and the disease specific AQL-5D having this 
highest. 
 
Table 5 presents mean and standard deviation of adjusted VAS scores (where dead=0) 
and  rank  scores  for  all  states  included  in  the  valuation  study.  The  number  of 
valuations per state other than the worst state is between 70 to 100 for all instruments, 
except the EQ-5D. There were fewer valuations per EQ-5D state (between 48 to 98), 
since there were more states valued from that instrument. The worst state of each 
instrument had between 490 to 501 valuations.  Perhaps unsurprisingly all instruments 
have a wide range of VAS values, where the AQL-5D (condition specific measure) 
has a smaller range and this is consistent with the published value set utility range 
using TTO (0.431 to 1). The results suggest important differences in the value range 
of each of the instruments (with mean worst  state values ranging  from 0.075 to 
0.324). The inter-quartile range suggests that adjusted values vary across individuals 
and potentially across card blocs. There are no logical inconsistencies in the mean 
VAS scores, mean rank values or value set for these states for each instrument. 
 
We modelled the VAS utility value on the vector of all health states and background 
characteristics using a maximum likelihood random effects model. No background 
characteristics variables were significant and hence to minimise error the mean values 
for health states are reported here rather than predicted values using the regression 
model. 
 
Figure 2 plots adjusted VAS values and the published value sets for each instrument, 
indicating the different  relationships for each instrument. Note that the published 
value sets are typically not based on VAS.  It shows that EQ-5D VAS values from our 
study are  mostly higher  than the published  TTO-based  values.  Overall our  VAS 
values have a smaller range and spread than the published value set utility scores 
using other valuation methods. The results indicate that for milder health and well- 
being states the VAS value is often lower than the published value set utility score, 
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whereas for more severe states the VAS value is often higher than the published value 
set utility score. This relationship is present for each instrument with the exception of 
the AQL-5D where all VAS values are lower than the published value set utility 
scores, and EQ-5D where most VAS values are higher than the published TTO and 
VAS value set utility scores (as shown in table 5). Figure 3 plots rank scores and the 
published value sets for each instrument. The relationship is largely similar yet the 
pattern cannot be precisely determined as our rank values and the value sets are 
measured using different scales. 
 
4.3 VAS and rank differences 
Respondents were able to change the ordering of the health states for the rank and 
VAS tasks. The Spearman rank correlation coefficient between all rank and implied 
ranking observations using VAS values is 0.9778, demonstrating high correlation. 
However,  rankings and  implied  rankings using  the VAS  values  are different  for 
32.7% of respondents, yet only for 7.5% of all possible responses. Although one third 
of all respondents have different rankings and implied rankings using the VAS values, 
this is often only for a small number of states and not for entire rank tasks. In total 
12.0% of all respondents have one or more differences for every task between their 
rankings and implied rankings. Differences in rankings and implied rankings vary 
across card bloc from 2.2% to 12.0% of total responses per bloc, but there is no clear 
pattern between differences and the combinations of instruments valued. 
 
4.4 EQ-5D results 
The orthogonal array used to select the EQ-5D states in the valuation study enables 
the estimation of an additive function to value all 243 EQ-5D states. Figure 4 shows 
the relationship between predicted adjusted VAS score and the MVH EQ-5D VAS 
published value set for all EQ-5D states. Predicted adjusted VAS score is estimated 
using  a  maximum  likelihood  random effects  model using  the  model specified  in 
Dolan (1997) using the adjusted VAS data. All main effects coefficients are of the 
expected sign and all are significant at the 1% level with the exception of the dummy 
variable representing severe problems in usual activities. The ‘N3’ term, a dummy 
variable for states with at least one dimension at the most severe level, is significant 
but smaller (0.107) than that in the MVH EQ-5D VAS published value set (0.269). 
Figure 4 shows that predicted adjusted VAS scores are similar to the MVH VAS 
value set for mild states, yet indicates a different relationship for more severe states 
where typically our model overpredicts. The majority of states with at least one 
dimension  at  the  most  severe  level,  that  is  those  with  an  ‘N3’  term were  over 
predicted (ICC = 0.899). 
 
5. Discussion 
One advantage of VAS or ranking for this type of study over TTO or SG is that 
respondents see multiple states at the same time. Respondents rank and rate states 
from different instruments simultaneously and hence the ordering of states is explicit 
rather than implicit. Respondents were able to value states from different instruments 
alongside each other using VAS and ranking methods and extremely high completion 
rates were achieved at the task level. 
 
Each   card   bloc   appears   feasible   and   comparable   in   terms   of   completion, 
understanding, difficulty and effort. Yet the combination of instruments in a given 
task may affect VAS values. Three of the instruments included in the study are 
designed for specific patient groups; the HUI2 is designed for children and ICECAP 
and OPUS are designed for older people. However, the descriptive systems for OPUS 
and ICECAP do not include any words or dimensions that are applicable only for 
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older people or that indicate the measure is designed for older people. The HUI2 
descriptive system used in the study does not include words that indicate that the 
measure is designed for children, and this is in accordance with the HUI questionnaire 
that is used to determine the HUI2 and HUI3 health states and utility scores for 
patients. Therefore respondents will not realise that the measures are designed for 
different patient groups. Table 3 indicates that simultaneous valuation of HUI2 and 
ICECAP or OPUS is feasible as the two easiest blocs include HUI2 and either OPUS 
or ICECAP. One of the instruments included in the study is condition-specific, the 
AQL-5D for asthma. Valuing AQL-5D alongside other instruments may make 
respondents more aware of other aspects of health that are not explicitly included in 
the descriptive system than when the AQL-5D is valued alone. Table 3 suggests that 
valuing AQL-5D alongside generic measures is feasible as although AQL-5D appears 
in the most difficult card blocs it also appears in one of the easiest.. 
 
The rankings and implied rankings from the VAS values were found to differ for one 
third of respondents. This is expected as they are different tasks and respondents were 
able to revise their orderings at any time. However, the relationship between the 
published value set and rank and VAS values is largely similar as demonstrated in 
figures 2 and 3 and only 12.0% of respondents have differences in every task between 
their rankings and implied rankings using VAS. A separate piece of work is being 
undertaken to convert the rank data into cardinal values using a mixed logit model. 
The next part of the study will involve analysis on the rank and VAS data to estimate 
the relationship between the instruments. This stage will indicate the degree to which 
the use of VAS or rank values are important. 
 
This paper presents the detailed methods of the valuation study and basic descriptive 
statistics of the rank and VAS values. Further analyses of the VAS and rank data will 
be reported elsewhere. The next stage of the study will be reported in Rowen et al, 
2009. The final stage of the study involves the use of these results to map between the 
six measures of health and quality of life using the rank and VAS data. This will 
involve estimating the relationship between the 13 health states valued for each 
instrument and the original value set. This will be done using the rank and VAS data 
collected in the valuation study. This mapping uses preferences rather than statistical 
association and is better able to take advantage of diversity in descriptive systems for 
different measures. This provides a way of mapping between different preference- 
based measures that can be used for evidence synthesis and cross programme 
comparisons in studies using different preference-based measures. This will enable 
the integration of evidence from a larger range of studies for economic evaluation and 
hence enable better cost effectiveness models to be produced. 
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Table 1 Measures of health and quality of life 
 
Instrument Summary Dimensions Levels Unique 
states 
Reference Valuation technique 
and reference for value 
set used here 
Value 
set 
range 
EQ-5D Generic 5 dimensions: Mobility, self-care, usual 3 levels: no problems, 243 Brooks Time trade-off, -0.594 to 
  activity, pain/discomfort and some problems,  (1996) Dolan (1997) 1 
  anxiety/depression extreme problems     
SF-6D Generic 6 dimensions: Physical functioning, role Between 4 and 6 levels, 18,000 Brazier et al. Standard gamble, 0.271 to 
  limitations, social functioning, pain, mental depends on the  (2002) Brazier and Roberts 1 
  health, vitality dimensions   (2004)  
HUI2 Generic for 7 dimensions: Sensation, mobility, emotion, 4 or 5 levels, depends 8,000 Torrance et VAS mapped to -0.0552 
 children cognition, self care, pain, fertility on the dimensions  al. (1996) standard gamble, 
McCabe et al. (2005) 
to 1 
AQL-5D Condition specific 5 dimensions: Concern about asthma, 5 levels: no problems to 3,125 Young et al. Time trade-off, 0.431 to 
 for asthma shortness of breath, weather and pollution extreme problems  (2007) Yang et al. (2007) 1 
  stimuli, sleep impact and activity limitations      
ICECAP Capability measure 5 dimensions: Attachment, security, role, 4 levels: all, a lot, a 1,024 Grewal et al. Best-worst scaling, 0 to 1 
 for older people in 
UK 
enjoyment, control little, none  (2006) Coast et al. (2008)  
OPUS Social care 5 dimensions: Food and nutrition, personal 3 levels: no unmet 243 Ryan et al. Discrete choice 0 to 1 
 outcome measure care, safety, social participation, control over needs, low unmet  (2006) experiment,  
 for older people daily living needs, high unmet   Ryan et al. (2006)  
   needs     
 1
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Table 2 Characteristics of respondents 
 
 
Included respondents 
(n=499) 
 
 
South 
Yorkshire2 
 
 
England 
Mean age (s.d.) 48.5(17.9) - - 
Female 49.9% 51.2% 51.3% 
Married/Partner 69.1% - - 
Employed or self-employed 49.1% 56.1% 60.9% 
Unemployed 1.4% 4.1% 3.4% 
Long-term sick 3.6% 7.7% 5.3% 
Full-time student 4.2% 7.5% 7.3% 
Retired 30.5% 14.4% 13.5% 
Own home outright or with a mortgage 86.1% 64.0% 68.7% 
Renting property 13.8% 36.0% 31.3% 
Secondary school is highest level of education 43.9% - - 
EQ-5D score (s.d.) 0.86(0.23) - - 
Found valuation task difficult (judged by 
respondent) 
Doubtful whether the respondent understood the 
tasks (judged by interviewer) 
29.3% - - 
 
4.1% - - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
Statistics for South Yorkshire Health Authority and for England in the Census 2001. Questions used in this study and 
the census are not identical. The census includes persons aged 16 and above whereas this study only surveys persons 
aged 18 and above. 
  
Table 3 Duration, completion, difficulty, understanding and effort by card bloc 
 
 Card bloc 
 Most difficult blocs Easiest blocs 
Instruments 
 
 
N 
 
Duration (minutes) 
 
Number of missing VAS responses 
Number of missing rank responses 
 
Spearman rank correlation coefficient for rank and 
implied rank from VAS values 
 
Difficulty of questions, self-reported 
Very difficult 
Quite difficult 
Neither 
Fairly easy 
Very easy 
 
Understanding, reported by interviewer 
Understood and performed exercises easily 
Some problems but seemed to understand in the 
end 
Doubtful whether the respondent understood the 
exercises 
 
Effort and concentration, reported by interviewer 
Concentrated very hard 
Concentrated fairly hard 
Didn't concentrate very hard 
Concentrated at start but lost interest towards end 
AQL-5D SF-6D HUI2 AQL-5D 
OPUS ICECAP OPUS HUI2 
ICECAP AQL-5D EQ-5D ICECAP 
24 25 27 25 
 
34 41 32 32 
 
0(0%) 1(0.2%) 33(5.1%) 5(0.8 %) 
0(0%) 0(0%) 32(4.9%) 1(0.2%) 
 
0.959 0.967 0.964 0.989 
n n n n 
3(12.5%) 3(12.0%) 0(0%) 0(0%) 
8(33.3%) 4(16.0%) 4(14.8%) 4(16.0%) 
8(33.3%) 4(16.0%) 4(14.8%) 10(40.0%) 
3(12.5%) 13(52.0%) 13(48.1%) 9(36.0%) 
2(8.3%) 1(4.0%) 4(14.8%) 1(4.0%) 
 
 
17(70.8%) 15(60.0%) 23(85.2%) 16(64.0%) 
 
7(29.2%) 8(32.0%) 1(3.7%) 8(32.0%) 
 
0(%) 2(8.0%) 2(7.4%) 0(0%) 
 
 
 
15(62.5%) 16(64.0%) 19(70.4%) 12(48.0%) 
9(37.5%) 6(24.0%) 5(18.5%) 11(44.0%) 
0 (0%) 1(4.0%) 1(3.7%) 0 (0%) 
0(0%) 2(8.0%) 1(3.7%) 1(4.0%) 
 
 
 
Table 4 Adjusted VAS score and mean rank of worst and highest states by instrument 
Instrument Highest state valued Worst state 
 
 Health Mean VAS Mean rank Health Mean VAS Mean rank 
state (s.d.) (s.d.) state (s.d.) (s.d.) 
EQ-5D 11111 0.909 (0.159) 2.12 (1.02) 33333 0.075 (0.228) 6.75 (1.03) 
SF-6D 211111 0.860 (0.133) 2.37 (0.92) 645655 0.266 (0.250) 5.63 (1.22) 
HUI2 112222 0.706 (0.210) 2.71 (0.97) 455445 0.077 (0.229) 6.87 (0.94) 
AQL-5D 13321 0.717 (0.205) 3.14 (1.21) 55555 0.324 (0.240) 5.39 (1.23) 
ICECAP 12321 0.872 (0.114) 2.26 (0.46) 44444 0.227 (0.275) 5.76 (1.29) 
OPUS 1111 0.899 (0.111) 2.05 (0.57) 3333 0.223(0.238) 5.75 (1.24) 
Note: Rank scores are coded in order of preference from 1 to 8, allowing ties, where 1 is the most 
preferred state. 
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Table 5 Health states with observed raw and adjusted VAS scores and published value set 
 
 
Health state description Number of 
valuations 
Mean adjusted VAS (s.d.) Median (Interquartile 
range) for adjusted VAS 
VAS published value set 
utility value (where 
Mean rank 
(s.d.) 
Median (Interquartile 
range) rank 
    available
3
   
EQ-5D       
11111 (best state) 74 0.909(0.159) 0.95(0.900-1.000) 1 2.12(1.02) 2(2-2) 
11322 50 0.709(0.200) 0.70(0.647-0.861) 0.403 2.70(0.97) 2(2-3) 
12311 76 0.676(0.213) 0.70(0.540-0.848) 0.457 2.95(1.24) 3(2-3) 
21113 75 0.604(0.223) 0.67(0.500-0.750) 0.435 3.48(1.17) 3(3-4) 
13211 74 0.604(0.234) 0.60(0.498-0.800) 0.455 3.24(1.10) 3(2-4) 
11223 75 0.577(0.238) 0.60(0.433-0.750) 0.392 3.71(1.23) 4(3-4) 
22212 98 0.570(0.231) 0.60(0.400-0.750) 0.587 3.19(1.16) 3(2-4) 
21331 50 0.540(0.212) 0.59(0.374-0.700) 0.308 3.98(1.12) 4(3-5) 
23121 75 0.492(0.248) 0.50(0.330-0.688) 0.330 3.72(1.02) 4(3-4) 
13132 76 0.438(0.299) 0.40(0.250-0.619) 0.251 4.32(1.22) 4(3-5) 
12133 47 0.381(0.384) 0.37(0.211-0.612) 0.243 4.23(1.37) 4(3-5) 
31112 47 0.392(0.261) 0.40(0.200-0.600) 0.385 4.47(1.46) 4(3-6) 
31231 50 0.347(0.224) 0.30(0.166-0.493) 0.247 4.60(1.31) 4(4-6) 
32121 48 0.288(0.264) 0.25(0.150-0.450) 0.272 5.29(1.41) 6(5-6) 
33313 75 0.197(0.235) 0.15(0.053-0.300) 0.099 5.33(1.15) 6(5-6) 
33333 (worst state) 496 0.075(0.227) 0.05(0.000-0.150) -0.072 6.75(1.03) 7(6-7) 
 
SF-6D 
211111 99 0. 860(0.133) 0.90(0.847-0.947) 2.37(0.92) 2(2-2) 
211211 76 0.777(0.182) 0.85(0.697-0.900) 2.49(1.10) 2(2-2) 
112221 74 0.754(0.204) 0.80(0.675-0.900) 2.55(1.04) 2(2-3) 
111453 99 0.666(0.227) 0.75(0.526-0.850) 2.94(1.16) 3(2-3) 
214411 76 0.652(0.222) 0.70(0.500-0.830) 3.04(1.33) 3(2-4) 
 
3 
EQ-5D VAS values quoted in ‘The Measurement and Valuation of Health; First report on the main survey’, The MVH Group, May 1994. Values used are the VAS tariff of 
means: Whole population – 10 year duration. 
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Health state description Number of Mean adjusted VAS (s.d.) Median (Interquartile VAS published value set Mean rank Median (Interquartile 
 valuations  range) for adjusted VAS utility value (where 
available
3
 
(s.d.) range) rank 
623133 76 0.540(0.224) 0.58(0.400-0.700)  3.97(1.26) 4(3-5) 
424421 74 0.532(0.241) 0.55(0.350-0.730)  3.38(1.26) 3(2-4) 
311655 99 0.490(0.237) 0.48(0.300-0.700)  4.25(0.99) 4(4-5) 
545622 74 0.484(0.234) 0.50(0.300-0.650)  4.18(1.22) 4(4-5) 
422655 76 0.411(0.267) 0.40(0.239-0.650)  4.76(1.24) 5(4-6) 
624343 74 0.411(0.195) 0.40(0.250-0.575)  4.22(1. 4(3-5) 
     22)  
535645 99 0.340(0.242) 0.33(0.150-0.500)  4.90(1.21) 5(4-6) 
645655 (worst state) 498 0.266(0.250) 0.25(0.1()00-0.400)  5.63(1.22) 6(5-7) 
 
AQL-5D 
13321 72 0.717(0.205) 0.79(0.590-0.876) 3.14(1.21) 3(2-3.75) 
21223 98 0.701(0.205) 0.76(0.598-0.850) 3.02(1.25) 3(2-3) 
53411 72 0.647(0.212) 0.70(0.500-0.830) 3.13(1.28) 3(2-4) 
32441 76 0.619(0.197) 0.63(0.500-0.790) 3.35(1.27) 3(2-4) 
12543 100 0.608(0.203) 0.60(0.500-0.750) 3.16(1.10) 3(2-4) 
45143 76 0.551(0.200) 0.55(0.444-0.700) 3.59(1.12) 4(3-4) 
23534 76 0.550(0.205) 0.60(0.400-0.700) 3.67(1.12) 3(3-4) 
52314 100 0.515(0.226) 0.52(0.350-0.689) 3.90(1.32) 4(3-5) 
15355 76 0.510(0.205) 0.50(0.365-0.600) 4.37(1.26) 5(3-5) 
34254 72 0.424(0.324) 0.40(0.261-0.637) 4.07(1.09) 4(3-5) 
55424 98 0.432(0.210) 0.43(0.300-0.586) 4.67(1.13) 5(4-6) 
34554 72 0.403(0.274) 0.40(0.250-0.600) 4.69(1. 5(4-5.75) 
    12)  
55555 (worst state) 494 0.324(0.240) 0.30(0.158-0.480) 5.39(1.23) 5(5-6) 
 
HUI2 
112222 75 0.706(0.210) 0.75(0.600-0.856) 2.71(0.97) 2(2-3) 
121132 76 0.661(0.194) 0.69(0.550-0.800) 3.20(1.06) 3(2-4) 
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Health state description Number of Mean adjusted VAS (s.d.) Median (Interquartile VAS published value set Mean rank Median (Interquartile 
 valuations  range) for adjusted VAS utility value (where 
available
3
 
(s.d.) range) rank 
112123 99 0.639(0.235) 0.69(0.500-0.849)  3.19(1.31) 3(2-4) 
331131 98 0.499(0.375) 0.50(0.327-0.713)  3.85(1.25) 4(3-5) 
323331 76 0.490(0.224) 0.50(0.376-0.650)  3.76(1.20) 4(3-5) 
314431 75 0.442(0.267) 0.45(0.246-0.622)  4.52(1.36) 5(3-6) 
234111 74 0.428(0.192) 0.40(0.308-0.533)  4.18(1.34) 4(3-5) 
344222 76 0.407(0.244) 0.40(0.250-0.550)  4.45(1.27) 4(4-6) 
133444 98 0.350(0.355) 0.30(0.150-0.600)  4.50(1.38) 4.5(4-6) 
144325 75 0.369(0.296) 0.30(0.150-0.621)  4.79(1.45) 5(4-6) 
125425 77 0.323(0.269) 0.30(0.119-0.495)  5.13(1.22) 5(4-6) 
445234 98 0.155(0.223) 0.15(0.037-0.275)  5.98(0.79) 6(6-6) 
455445 (worst state) 501 0.077(0.229) 0.05(0.000-0.150)  6.87(0.94) 7(7-7) 
 
ICECAP 
12321 100 0.872(0.114) 0.90(0.850-0.950) 2.26(0.46) 2(2-2.75) 
21131 73 0.857(0.149) 0.90(0.817-0.950) 2.12(0.47) 2(2-2) 
31212 72 0.805(0.151) 0.85(0.709-0.900) 2.21(0.60) 2(2-2) 
22242 72 0.735(0.217) 0.80(0.650-0.900) 2.86(1.35) 2(2-3) 
23324 100 0.682(0.217) 0.75(0.513-0.879) 2.82(1.06) 3(2-3) 
33333 72 0.567(0.290) 0.62(0.400-0.780) 3.35(1.24) 3(2-4) 
14344 100 0.569(0.261) 0.58(0.350-0.800) 3.46(1.09) 3(3-4) 
43111 72 0.538(0.227) 0.55(0.400-0.706) 3.40(1.33) 3(2-4) 
44143 73 0.398(0.275) 0.44(0.211-0.553) 4.33(1.08) 4(3-5) 
43443 72 0.386(0.217) 0.36(0.250-0.600) 4.65(1.06) 5(4-6) 
43334 72 0.352(0.245) 0.30(0.190-0.500) 4.96(1.37) 5(4-6) 
42444 99 0.343(0.258) 0.30(0.150-0.550) 4.60(1.05) 4(4-5) 
44444 (worst state) 490 0.226(0.275) 0.16(0.052-0.400) 5.76(1.29) 6(5-7) 
 
OPUS 
1111 74 0.899(0.111) 0.94(0.891-0.952) 2.05(0.57) 2(2-2) 
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Health state description Number of Mean adjusted VAS (s.d.) Median (Interquartile VAS published value set Mean rank Median (Interquartile 
 valuations  range) for adjusted VAS utility value (where 
available
3
 
(s.d.) range) rank 
2121 74 0.663(0.213) 0.71(0.538-0.823)  2.78(1.02) 2.5(2-3) 
3121 76 0.641(0.199) 0.65(0.500-0.800)  2.92(0.88) 3(2-3) 
2212 99 0.596(0.224) 0.60(0.450-0.798)  3.04(1.21) 3(2-4) 
3132 76 0.519(0.194) 0.50(0.350-0.690)  3.69(0.87) 4(3-4) 
2123 74 0.451(0.300) 0.46(0.285-0.692)  3.78(1.56) 4(2-5) 
1322 99 0.480(0.258) 0.50(0.248-0.700)  3.94(1. 4(3-5) 
     43)  
1233 99 0.451(0.244) 0.45(0.250-0.650)  3.97(1.12) 4(3-5) 
3221 99 0.445(0.241) 0.40(0.260-0.645)  4.10(1.35) 4(3-5) 
2331 74 0.409(0.253) 0.41(0.239-0.600)  4.39(1.21) 4(3-5) 
3313 74 0.386(0.224) 0.40(0.219-0.550)  4.66(1.02) 5(4-5) 
1333 74 0.318(0.329) 0.27(0.150-0.550)  4.64(1.53) 5(3.75-6) 
3333 (worst state) 496 0.223(0.238) 0.20(0.071-0.350)  5.75(1.24) 6(5-7) 
 
Best state 1488 0.999(0.010) 1.00(1.000-1.000) 1.00(0.08) 1(1-1) 
Dead 1488 0.000(0.001) 0.00(0.000-0.000) 7.59(0.85) 8(7-8) 
 Task 1 Task 2 Task 3 
 D1   D1   E1  
 D2   D4   E4  
 D3   D5   E5  
 E1   F1   F1  
 E2   F2   F4  
 E3   F3   F5  
Best state Best state Best state 
Dead Dead Dead 
 
Task 1 Task 2 Task 3 
 B1   B1   C1  
 B6   B8   C12  
 B7   B9   C13  
 C1   D1   D1  
 C10   D10   D12  
 C11   D11   D13  
Best state Best state Best state 
Dead Dead Dead 
 
Task 1 Task 2 Task 3 
 F1   F1   B1  
 F6   F8   B12  
 F7   F9   B13  
 B1   C1   C1  
 B10   C10   C12  
 B11   C11   C13  
Best state Best state Best state 
Dead Dead Dead 
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Figure 1 States for the ranking and VAS tasks for blocs 1-6 out of 20 
 
BLOC 1 – A, B, C. Respondents, n=25 
e.g. A=EQ-5D, B=SF-6D, C=HUI2. 
A1 = EQ-5D state 11111, B1 = SF-6D state 645655 
 
 
BLOC 2 – D, E, F. n=25 
 
Task 1 Task 2 Task 3 
 A1   A1   B1  
 A2   A4   B4  
 A3   A5   B5  
 B1   C1   C1  
 B2   C2   C4  
 B3   C3   C5  
Best state Best state Best state 
Dead Dead Dead 
 
BLOC 3 – E, F, A. n=25 BLOC 4 – B, C, D. n=25 
 
Task 1 Task 2 Task 3 
 E1   E1   F1  
 E6   E8   F8  
 E7   E9   F9  
 F1   A1   A1  
 F6   A6   A8  
 F7   A7   A9  
Best state Best state Best state 
Dead Dead Dead 
 
BLOC 5 – D, A, E. n=25 BLOC 6 – F, B, C. n=25 
 
Task 1 Task 2 Task 3 
 D1   D1   A1  
 D6   D8   A12  
 D7   D9   A13  
 A1   E1   E1  
 A10   E6   E8  
 A11   E7   E9  
Best state Best state Best state 
Dead Dead Dead 
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Figure 2 Comparison of adjusted VAS value and published value set 
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Figure 3 Comparison of rank value and published value set 
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Figure 4 Comparison of EQ-5D VAS value set for all EQ-5D states and predicted 
adjusted VAS score using maximum likelihood random effects regression4 
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4  
EQ-5D VAS values quoted  in  MVH,  1994. Values used  are the VAS tariff of means: Whole 
population – 10 year duration. 
